Exclusive

Publication

Byline

Location

Singapore Clinical Trial: CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion

Singapore, Sept. 19 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitax... Read More


Singapore Clinical Trial: A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients with Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)

Singapore, Sept. 19 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus A... Read More


Singapore Clinical Trial: A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients with Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)

Singapore, Sept. 19 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus A... Read More


Singapore Clinical Trial: Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations

Singapore, Sept. 19 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvan... Read More


Clinical Trial: Developing and Testing a Method for Engagement in Research Using WhatsApp

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07826962) titled 'Developing and Testing a Method for Engagement in Research Using WhatsApp' on Sept. 10. B... Read More


Clinical Trial: The Clinical and Ultrasound Outcomes of Double-row "Knotless" Rotator Cuff Repairs Using the Montgolfier Technique

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07828366) titled 'The Clinical and Ultrasound Outcomes of Double-row "Knotless" Rotator Cuff Repairs Using t... Read More


Clinical Trial: PEARL Trial: Partial TACE Enhancing Anti-tumor Response With Lenvatinib in Unresectable HCC

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07827807) titled 'PEARL Trial: Partial TACE Enhancing Anti-tumor Response With Lenvatinib in Unresectable HC... Read More


Clinical Trial: Premedication With Dexamethasone for Preventing Interstitial Lung Disease in Patients With Breast Cancer Treated With Trastuzumab Deruxtecan

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07828054) titled 'Premedication With Dexamethasone for Preventing Interstitial Lung Disease in Patients With... Read More


Clinical Trial: FueL Use During eXercise in Males and Females

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07829237) titled 'FueL Use During eXercise in Males and Females' on Sept. 14. Brief Summary: This study wil... Read More


Clinical Trial: Impact of Overt and Subclinical Hypothyroidism on Liver Fibrosis in Patients With MASLD

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07827430) titled 'Impact of Overt and Subclinical Hypothyroidism on Liver Fibrosis in Patients With MASLD' o... Read More